Insight Molecular Diagnostics Inc.
IMDXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for IMDX. That does not mean none is planned.
Get an email about IMDX's next catalysts
Track Insight Molecular Diagnostics (IMDX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 2 past
No catalysts found.
How IMDX's past catalysts played out
Market Overview
Stock performance and key metrics
Klarity CL, Cylcosporine/Loteprednol Etabonate Preservative Free
Dry Eye
99mTc-MIP-1404 Injection
Prostate Cancer
UltratraceTM Iobenguane I 131 Imaging
Neuroblastoma
NeuVax vaccine
Breast Cancer
Iodofiltic acid I 123
Acute Coronary Syndrome
Ultratrace Iobenguane (MIBG) I 131
Pheochromocytoma
UltratraceTM Iobenguane I 131 Therapy
Neuroblastoma
99mTc-MIP-1404
Prostate Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Klarity CL, Cylcosporine/Loteprednol Etabonate Preservative Free | Phase 3 | Dry Eye | - | - |
99mTc-MIP-1404 Injection | Phase 3 | Prostate Cancer | - | - |
UltratraceTM Iobenguane I 131 Imaging | Phase 2 | Neuroblastoma | - | - |
NeuVax vaccine | Phase 2 | Breast Cancer | - | - |
Iodofiltic acid I 123 | Phase 2 | Acute Coronary Syndrome | - | - |
Ultratrace Iobenguane (MIBG) I 131 | Phase 2 | Pheochromocytoma | - | - |
UltratraceTM Iobenguane I 131 Therapy | Phase 2 | Neuroblastoma | - | - |
99mTc-MIP-1404 | Phase 2 | Prostate Cancer | - | - |
Frequently asked questions
What is in Insight Molecular Diagnostics Inc.'s drug pipeline?β
CatalystAlert tracks 8 drug candidates in Insight Molecular Diagnostics Inc.'s (IMDX) pipeline across Phase 3, Phase 2. Its lead program is 99mTc-MIP-1404 Injection (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Insight Molecular Diagnostics Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Insight Molecular Diagnostics Inc. (IMDX) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track IMDX biotech catalysts?β
Add IMDX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Insight Molecular Diagnostics Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
